Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Vyne Therapeutics Inc."
Count: 35
Selected: 0
NCT IDTitle
NCT04927572Pharmacokinetics, Efficacy and Safety of FMX114 Versus Vehicle in Adults With Atopic Dermatitis
NCT03841331Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Chronic Pruritus of Unknown Origin
NCT03677401Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
NCT03546816Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
NCT03540160Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
NCT03343639Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis
NCT03282591Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
NCT02975271Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
NCT02975206Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
NCT02196324A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)
NCT01951274VPD-737 for Treatment of Chronic Pruritus
NCT00835718A Study of MK0594 in Patients With Alcohol Dependence (0594-020)
NCT00290563Safety and Efficacy of MK0594 to Treat Overactive Bladder (0594-003)
NCT03743038A Study Comparing Two Topicals in the Treatment of Acne Vulgaris
NCT02250859A Pharmacokinetic Study of Minocycline in Male and Female Volunteers
NCT04104685A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.
NCT03142451A Study (Study 1) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea
NCT04608500A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea
NCT03276936A Study to Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea
NCT02815280A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
NCT02815267A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne
NCT03271021A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris
NCT04070742Dermal Phototoxicity Study
NCT04070755Dermal Photo Allergic Skin Reaction
NCT04064125Dermal Cumulative Irritant Patch Study
NCT04052711A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design
NCT02239731Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients
NCT02601963Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea
NCT01134991Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Rosacea Patients
NCT01171326Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients
NCT01362010Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients
NCT04940767A Companion Treatment Study for Patients With Moderate to Severe Acne Vulgaris
NCT01494285Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients
NCT02094716A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies
NCT02654483Neurokinin-1 Receptor Antagonist for the Treatment of Itch in EB Patients